Stay updated on FLX475 Dose Escalation Trial in Combination With Pembrolizumab

Sign up to get notified when there's something new on the FLX475 Dose Escalation Trial in Combination With Pembrolizumab page.
Latest website image capture
Clouds background image

Latest updates to the FLX475 Dose Escalation Trial in Combination With Pembrolizumab page

  1. Check
    yesterday
    Change Detected
    Summary
    The footer site revision changed from v3.7.2 to v3.8.0.
    Difference
    0.2%
    Check dated 2026-11-04T00:40:52.000Z thumbnail image
  2. Check
    8 days ago
    No Change Detected
  3. Check
    15 days ago
    Change Detected
    Summary
    A banner announces an NIH terminology transition, and the site revision label changes from v3.7.1 to v3.7.2; the clinical trial record remains inaccessible.
    Difference
    1%
    Check dated 2026-10-21T00:37:43.000Z thumbnail image
  4. Check
    29 days ago
    Change Detected
    Summary
    The site revision label changed from v3.7.0 to v3.7.1 while the page continues to show a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-07T00:50:53.000Z thumbnail image
  5. Check
    36 days ago
    Change Detected
    Summary
    Deleted the 403 Forbidden error page content, including the HTML snippet and the Home link. The visible error notice on the study detail page is removed, leaving the standard page chrome and navigation.
    Difference
    0.5%
    Check dated 2026-09-30T00:56:16.000Z thumbnail image
  6. Check
    43 days ago
    Change Detected
    Summary
    The study page now displays a 403 Forbidden error, replacing the previous study content with an error message. The visible area shows the site's generic header and footer, indicating the record is inaccessible.
    Difference
    19%
    Check dated 2026-09-23T00:39:29.000Z thumbnail image
  7. Check
    50 days ago
    Change Detected
    Summary
    The page now shows Revision: v3.7.0, replacing the previous Revision: v3.6.6. This update reflects an upgrade to the site's content-management/template system rather than changes to the study details.
    Difference
    0.0%
    Check dated 2026-09-16T00:15:24.000Z thumbnail image

Stay in the know with updates to FLX475 Dose Escalation Trial in Combination With Pembrolizumab

Enter your email address, and we'll notify you when there's something new on the FLX475 Dose Escalation Trial in Combination With Pembrolizumab page.